On February 7, 2024, China CMDE.NMPA issued the draft guidance “Guideline for registration review of estrogen receptor and progesterone receptor antibody reagents and detection kits (2023 revised version)”. CMDE called for the public comments on the draft guideline before February 29, 2024.